FDA Approved: TRANYLCYPROMINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Tranylcypromine sulfate by Actavis Pharma, Inc., resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Tranylcypromine sulfate (Tranylcypromine sulfate)

Snippet

SUPPL AP for TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE)